-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Cardiff Oncology, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2011 to 2023.
- Cardiff Oncology, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $1.18M, a 25.4% decline year-over-year.
- Cardiff Oncology, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $4.17M, a 11.2% decline year-over-year.
- Cardiff Oncology, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $4.51M, a 5.95% increase from 2022.
- Cardiff Oncology, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $4.26M, a 31.6% increase from 2021.
- Cardiff Oncology, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $3.23M, a 83.2% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)